共 42 条
- [31] A Randomized Study of the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Clopidogrel in Three Different CYP2C19 Genotype Groups of Healthy Japanese SubjectsJOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2015, 22 (11) : 1186 - 1196Kobayashi, MasahikoKajiwara, MiyukiHasegawa, Setsuo
- [32] Cigarette Smoking Does Not Enhance Clopidogrel Responsiveness After Adjusting VerifyNow P2Y12 Reaction Unit for the Influence of Hemoglobin LevelJACC-CARDIOVASCULAR INTERVENTIONS, 2016, 9 (16) : 1680 - 1690Kim, Yun GiSuh, Jung-WonKang, Si-HyuckPark, Jin JooYoon, Chang-HwanCho, Young-SeokYoun, Tae-JinChae, In-HoChoi, Dong-JuKim, Hyo-Soo
- [33] Patients carrying CYP2C19 loss of function alleles have a reduced response to clopidogrel therapy and a greater risk of in-stent restenosis after endovascular treatment of lower extremity peripheral arterial diseaseJOURNAL OF VASCULAR SURGERY, 2014, 60 (04) : 993 - 1001Guo, BaoleiTan, QiwenGuo, DaqiaoShi, ZhenyuZhang, ChunyanGuo, Wei
- [34] Triple Antithrombotic Therapy With Aspirin, P2Y12 Inhibitor, and Warfarin After Percutaneous Coronary Intervention: An Evaluation of Prasugrel or Ticagrelor Versus ClopidogrelJOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2017, 22 (06) : 546 - 551Verlinden, Nathan J.Coons, James C.Iasella, Carlo J.Kane-Gill, Sandra L.
- [35] Effect of CYP2C19*2 and *3 Loss-of-Function Alleles on Platelet Reactivity and Adverse Clinical Events in East Asian Acute Myocardial Infarction Survivors Treated With Clopidogrel and AspirinCIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2011, 4 (06) : 585 - U98Jeong, Young-HoonTantry, Udaya S.Kim, In-SukKoh, Jin-SinKwon, Tae JungPark, YongwhiHwang, Seok-JaeBliden, Kevin P.Kwak, Choong HwanHwang, Jin-YongGurbel, Paul A.
- [36] Cost Effectiveness of Genotype-Guided Antiplatelet Therapy in Asian Ischemic Stroke Patients: Ticagrelor as an Alternative to Clopidogrel in Patients with CYP2C19 Loss of Function MutationsCLINICAL DRUG INVESTIGATION, 2020, 40 (11) : 1063 - 1070Narasimhalu, KaavyaAng, Yoong KweiTan, Doreen Su YinDe Silva, Deidre AnneTan, Kelvin Bryan
- [37] Association of CYP2C19 genotypes with postoperative atrial fibrillation after coronary artery bypass surgeryCTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (06):Jiang, QinHuang, KeliHan, LizhuKong, HongYang, ZhenglinHu, Shengshou
- [38] Effect of cytochrome CYP2C19 metabolizing activity on antidepressant response and side effects: Meta-analysis of data from genome-wide association studiesEUROPEAN NEUROPSYCHOPHARMACOLOGY, 2018, 28 (08) : 945 - 954Fabbri, ChiaraTansey, Katherine E.Perlis, Roy H.Hauser, JoannaHenigsberg, NevenMaier, WolfgangMors, OlePlacentino, AnnaRietschel, MarcellaSouery, DanielBreen, GeromeCurtis, CharlesLee, Sang-HyukNewhouse, StephenPatel, HamelO'Donovan, MichaelLewis, GlynJenkins, GregoryWeinshilboum, Richard M.Farmer, AnneAitchison, Katherine J.Craig, IanMcGuffin, PeterSchruers, KoenBiernacka, Joanna M.Uher, RudolfLewis, Cathryn M.
- [39] Clinical Outcomes and Sustainability of Using CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary InterventionCIRCULATION-GENOMIC AND PRECISION MEDICINE, 2018, 11 (04): : e002069Lee, Craig R.Sriramoju, Vindhya B.Cervantes, AlexandraHowell, Lucius A.Varunok, NicholasMadan, ShivanshuHamrick, KaseyPolasek, Melissa J.Lee, John AndrewClarke, MeganCicci, Jonathan D.Weck, Karen E.Stouffer, George A.
- [40] Evaluation of the incremental prognostic value of the combination of CYP2C19 poor metabolizer status and ABCB1 3435 TT polymorphism over conventional risk factors for cardiovascular events after drug-eluting stent implantation in East AsiansGENETICS IN MEDICINE, 2016, 18 (08) : 833 - 841Park, Mahn-WonHer, Sung HoKim, Chan JoonSunCho, JungPark, Gyung-MinKim, Tae-SeokChoi, Yun-SeokPark, Chul-SooKoh, Yoon-SeokPark, Hun-JunKim, Pum-JoonChung, Wook-SungSeung, Ki-BaeKim, Ho-SookShin, Jae-GookChang, Kiyuk